osimertinib
astrazeneca
['adaura']
(fi)asco 23: adaura: adjuvant osi vs placebo arm w/ tiny number receiving 1l osi at progression; probably no real os prospect: non-inf dfs, chemort -&gt; surg toxicity than more aggressive chemo alone -&gt; surg; conclusion that aggressive chemo alone is an advance
Oncologist | RadOnc | Stats #Rstats | Opinion | Politics | Never Trump